These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2499251)

  • 41. Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination.
    Cantoni L; Glauser MP; Bille J
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2348-53. PubMed ID: 1965105
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis.
    Perdikaris G; Giamarellou H; Pefanis A; Donta I; Karayiannakos P
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2289-94. PubMed ID: 8619584
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Sakoulas G; Eliopoulos GM; Alder J; Eliopoulos CT
    Antimicrob Agents Chemother; 2003 May; 47(5):1714-8. PubMed ID: 12709345
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fusidic acid alone or in combination with vancomycin for therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Fantin B; Leclercq R; Duval J; Carbon C
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2466-9. PubMed ID: 8285635
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sparfloxacin therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Maserati R; Cagni AE; Segú C
    Chemotherapy; 1996; 42(2):133-9. PubMed ID: 8697888
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.
    Fox PM; Lampen RJ; Stumpf KS; Archer GL; Climo MW
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2951-6. PubMed ID: 16940087
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats.
    Cantoni L; Wenger A; Glauser MP; Bille J
    J Infect Dis; 1989 May; 159(5):989-93. PubMed ID: 2708846
    [No Abstract]   [Full Text] [Related]  

  • 48. Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Chambers HF
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():117-22. PubMed ID: 1399943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis.
    Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 1999 Jan; 43(1):77-84. PubMed ID: 9869569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Chiang FY; Climo M
    Antimicrob Agents Chemother; 2003 Sep; 47(9):3002-4. PubMed ID: 12937013
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis.
    Entenza JM; Hohl P; Heinze-Krauss I; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 2002 Jan; 46(1):171-7. PubMed ID: 11751129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emergence of resistance to cephalothin and gentamicin during combination therapy for methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
    Chambers HF; Miller MH
    J Infect Dis; 1987 Mar; 155(3):581-5. PubMed ID: 3643249
    [No Abstract]   [Full Text] [Related]  

  • 54. Imipenem therapy of experimental Staphylococcus epidermidis endocarditis.
    Berry AJ; Johnston JL; Archer GL
    Antimicrob Agents Chemother; 1986 May; 29(5):748-52. PubMed ID: 3460523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.
    Asseray N; Jacqueline C; Le Mabecque V; Batard E; Bugnon D; Potel G; Caillon J
    Antimicrob Agents Chemother; 2005 Feb; 49(2):857-9. PubMed ID: 15673789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Thauvin C; Lemeland JF; Humbert G; Fillastre JP
    Antimicrob Agents Chemother; 1988 Jun; 32(6):919-21. PubMed ID: 3166360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactam.
    Backo M; Gaenger E; Burkart A; Chai YL; Bayer AS
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2565-8. PubMed ID: 10508047
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis.
    Pavie J; Lefort A; Ploy MC; Massias L; Chau F; Garry L; Denis F; Fantin B
    Antimicrob Agents Chemother; 2003 Jun; 47(6):2018-21. PubMed ID: 12760890
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of fosfomycin + vancomycin or gentamicin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
    Olay T; Vicente MV; Rodríguez A
    J Chemother; 1989 Jul; 1(4 Suppl):391-2. PubMed ID: 16312454
    [No Abstract]   [Full Text] [Related]  

  • 60. Y-688, a new quinolone active against quinolone-resistant Staphylococcus aureus: lack of in vivo efficacy in experimental endocarditis.
    Entenza JM; Marchetti O; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1889-94. PubMed ID: 9687379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.